Impact of the Microbiome on Time to Pregnancy and Pregnancy Outcomes in Fertile Women Attempting to Conceive
Launched by KAROLINSKA INSTITUTET · Nov 18, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how the microbiome—the community of microorganisms living in our bodies—affects the time it takes for women to become pregnant and the outcomes of their pregnancies. Researchers are specifically looking at women who have previously had at least one baby and are now planning to conceive again with the same partner.
To be eligible for this study, women need to be between 18 and 40 years old, have given birth in the last five years, and live in Sweden. Participants will be asked to provide samples to help the researchers study their microbiome and will complete a questionnaire online. This trial aims to better understand the role of microbial health in pregnancy, which could lead to improved support for women trying to conceive. If you meet the criteria and are interested, this could be a valuable opportunity to contribute to important research in fertility.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women with a previous live birth in the past 5 years and planning a new pregnancy with the same male partner.
- • 18-40 years of age
- • Swedish personal identity number and a Swedish address (to send a sampling self-kit)
- • Sufficient understanding of spoken and written Swedish or English to provide informed consent and complete the web-based questionnaire.
- Exclusion Criteria:
- • Women who do not have a child yet and plan to cease their contraception.
About Karolinska Institutet
Karolinska Institutet is a renowned medical university located in Sweden, recognized for its commitment to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the institution focuses on translating scientific discoveries into effective treatments and therapies, emphasizing patient-centered approaches. With a strong emphasis on collaboration and interdisciplinary research, Karolinska Institutet plays a pivotal role in addressing global health challenges and improving patient outcomes, leveraging its extensive network of experts and state-of-the-art facilities to drive clinical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stockholm, Huddinge, Sweden
Uppsala, , Sweden
Patients applied
Trial Officials
Lars Holmgren, Professor
Study Chair
Karolinska Institutet
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials